글로벌 해부병리학 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

해부병리학 시장 분석

디지털 병리학은 병리학자가 원격으로 작업할 수 있게 함으로써 전반적인 생산성을 높이고 케이스 백로그를 해결하는 데 도움을 줍니다. 지난 몇 년 동안 이러한 기술의 채택이 증가했습니다. 바이오마커의 임상적 사용이 증가함에 따라 병리학자는 분자 수준에서 질병 발병 기전을 결정하고 임상적 의사 결정을 더욱 안내하여 환자 결과를 개선할 수 있습니다.

해부병리학 시장 규모

글로벌 해부병리학 시장 규모는 2023년에 213억 달러로 평가되었으며, 2031년까지 362억 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 연평균 성장률은 6.85%입니다.

보고 범위 및 시장 세분화       

해부병리학 시장 정의

Anatomic pathology is a medical specialty that requires the microscopic, macroscopic, biochemical, immunologic, and molecular examination of organs and tissues in order to diagnose disease. Surgical pathology has evolved dramatically in recent years, from an ancient examination of whole bodies (autopsy) to modern techniques required for cancer diagnosis and prognosis to guide treatment decision-making in oncology.

Anatomic Pathology Market Dynamics

Drivers

• The rise in the cases of cancer

Cancer is the world's second leading cause of death, accounting for 10 million deaths by 2020. Cancer accounts for approximately one-sixth of all deaths worldwide. In 2020, 19.3 million new cancer cases were reported, with that number expected to rise to 30.2 million by 2040. This increase in cancer incidence can be attributed to the growing geriatric population as well as the overall population.

• The increase in adoption of advanced pathology equipment

The widespread use of advanced pathology equipment such as staining systems, gross imaging, and digital microscopes is poised to significantly improve anatomic pathological practises. Digital imaging solutions outperform traditional techniques in terms of specificity and accuracy, which increases service uptake in the anatomic pathology market.

• Regulatory Compliance

Maintaining compliance with medical reforms and regulations raises the demand for these solutions.

• Government investments for healthcare interoperability

The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the anatomic pathology market.

Opportunities

In oncology drug trials, anatomic pathology products and services are used to analyse quantitative data, detect morphological structures, detect pharmacodynamics markers, and understand drug mechanisms. It also stratifies trial subjects based on tissue responses to drugs. Tissue diagnostics enable efficient trials and retrospective studies by reducing the cost and time involved in these processes.

Restraints/Challenges

The scarcity of refurbished anatomic pathology instruments is a major impediment to the market's expansion. A number of end users, primarily small and medium-sized laboratories, seek cost-effectiveness and choose refurbished systems, particularly in price-sensitive developing-country markets. Given these considerations, the demand for refurbished anatomic pathology instruments is expected to rise in the coming years, as these systems provide the same functionality as new equipment at a lower cost. This is expected to reduce revenue for companies in the market that sell branded anatomic pathology instruments.

This anatomic pathology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the anatomic pathology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Anatomic Pathology Market

The COVID-19 outbreak has had an impact on every aspect of the diagnostics industry, including the anatomic pathology market, globally. Despite the availability of emergency and out-of-hours services in hospitals, patient visits to hospitals have decreased significantly in recent months. Cancer patients have emerged as one of the pandemic's most severely affected patient groups. COVID-19 has significantly impacted the number of patients who have cancer screening, diagnosis, and treatment. The increased pressure caused by the rising rate of COVID-19 hospitalisation had resulted in the re-profiling of many hospitals and departments, including oncology clinics, for treating COVID-19 patients.

Anatomic Pathology Market Scope

The anatomic pathology market is segmented on the basis of product and services, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product & Service

• Instrument
• Consumables

On the basis of product and services, the anatomic pathology market is segmented into instrument and consumables. Instruments are further segmented into Tissue Processing Systems, Microtomes, Cryostats and Others. Consumables are further segmented into reagents, stains & dyes, fixatives, antibodies and others.

Application

• Disease Diagnosis
• Drug Discovery and Development
• Other Applications

On the basis of application, the anatomic pathology market is segmented into disease diagnosis, drug discovery and development and other applications

End User

• Pathology Labs
• Research Institutes
• Hospitals
• Others

On the basis of end users, the anatomic pathology market is segmented into pathology labs, research institutes, hospitals and others.

Anatomic Pathology Market Regional Analysis

The anatomic pathology market is analysed and market size insights and trends are provided by country, product and services, application and end

users as referenced above.

The countries covered in the anatomic pathology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Due to the presence of major players and supportive government initiatives pertaining to training pathological programs, North America accounted for the largest revenue share. Because of favorable reimbursement policies in the United States, the increasing implementation of tissue-diagnostic related procedures in disease screening facilitates regional market growth. The Asia Pacific market is expanding due to rising demand for advanced imaging modalities, an increase in better patient care facilities, and several pathology laboratories franchising their presence. The presence of public agencies in China, such as the Pathology Branch of the Chinese Medical Association, which is aimed at assisting pathology projects, also contributes to the APAC market's rapid growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The anatomic pathology market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for anatomic pathology market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the anatomic pathology market. The data is available for historic period 2010-2020.

Anatomic Pathology Market Share

해부병리학 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 해부병리학 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 운영되는 해부병리학 시장 리더는 다음과 같습니다.

• F. 호프만-라 로슈 유한회사(스위스)
• 마일런 NV(미국)
• Teva Pharmaceutical Industries Ltd. (이스라엘)
• 사노피(프랑스)
• 파이저 주식회사(미국)
• GlaxoSmithKline plc (영국)
• 노바티스 AG(스위스)
• Bayer AG(독일)
• 엘리 릴리 앤드 컴퍼니(미국)
• 머크앤코(미국)
• 알러간(아일랜드)
• 아스트라제네카(영국)
• 존슨앤존슨 프라이빗 리미티드(미국)
• 시플라 주식회사(미국)
• Bausch Health Companies Inc. (캐나다)
• 애벗(미국)

해부병리학 시장의 최신 동향

• Hologic은 2021년 5월 다운스트림 애플리케이션을 위한 세포학 처리 및 검체 전송을 위한 ThinPrep GenesisTM 프로세서에 대한 FDA 시판 전 승인(PMA)을 받았습니다.
• PHC Holding Corporation은 진단 부문에서의 입지를 강화하기 위해 2019년 1월 Thermo Fisher Scientific의 Anatomical Pathology 사업 인수를 완료했습니다.

SKU-10842